Form 8-K - Current report:
SEC Accession No. 0001493152-24-044124
Filing Date
2024-11-08
Accepted
2024-11-07 21:09:28
Documents
40
Period of Report
2024-11-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38880
2 ex99-1.htm EX-99.1 28442
3 ex99-1_001.jpg GRAPHIC 166640
4 ex99-1_002.jpg GRAPHIC 678350
5 ex99-1_003.jpg GRAPHIC 343711
6 ex99-1_004.jpg GRAPHIC 274292
7 ex99-1_005.jpg GRAPHIC 298540
8 ex99-1_006.jpg GRAPHIC 342922
9 ex99-1_007.jpg GRAPHIC 306711
10 ex99-1_008.jpg GRAPHIC 308663
11 ex99-1_009.jpg GRAPHIC 261127
12 ex99-1_010.jpg GRAPHIC 288096
13 ex99-1_011.jpg GRAPHIC 309830
14 ex99-1_012.jpg GRAPHIC 275270
15 ex99-1_013.jpg GRAPHIC 321884
16 ex99-1_014.jpg GRAPHIC 295926
17 ex99-1_015.jpg GRAPHIC 292302
18 ex99-1_016.jpg GRAPHIC 367542
19 ex99-1_017.jpg GRAPHIC 267916
20 ex99-1_018.jpg GRAPHIC 290088
21 ex99-1_019.jpg GRAPHIC 329960
22 ex99-1_020.jpg GRAPHIC 342264
23 ex99-1_021.jpg GRAPHIC 276616
24 ex99-1_022.jpg GRAPHIC 287081
25 ex99-1_023.jpg GRAPHIC 415734
26 ex99-1_024.jpg GRAPHIC 372125
27 ex99-1_025.jpg GRAPHIC 325365
28 ex99-1_026.jpg GRAPHIC 136819
  Complete submission text file 0001493152-24-044124.txt   11508339

Data Files

Seq Description Document Type Size
29 XBRL SCHEMA FILE ltrn-20241107.xsd EX-101.SCH 3030
30 XBRL LABEL FILE ltrn-20241107_lab.xml EX-101.LAB 34240
31 XBRL PRESENTATION FILE ltrn-20241107_pre.xml EX-101.PRE 24175
42 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3793
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Filer) CIK: 0001763950 (see all company filings)

EIN.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39318 | Film No.: 241437734
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)